PFWA
STOK icon

Paces Ferry Wealth Advisors’s Stoke Therapeutics STOK Stock Holding History

Paces Ferry Wealth Advisors’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-100
Closed -$3K – 978
2020
Q3 		$3K Buy
+100
New +$2.85K ﹤0.01% 618

Other funds holding STOK

ALSV
ATP Life Science Ventures New York $898M AUM 84.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Paces Ferry Wealth Advisors's STOK Position: Q4 2020 in Review

Paces Ferry Wealth Advisors sold out of Stoke Therapeutics (STOK) in Q4 2020, closing a stake of 100 shares — an estimated $3K sold.

Paces Ferry Wealth Advisors first reported a position in STOK in Q3 2020 and held it in 1 quarter. The position peaked at $3K in Q3 2020. 93 funds tracked by Wall St. Rank hold STOK as of Q4 2020.

  • Paces Ferry Wealth Advisors reported no remaining Stoke Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Paces Ferry Wealth Advisors sold 100 Stoke Therapeutics shares in Q4 2020, an estimated $3K.
  • Paces Ferry Wealth Advisors first reported a position in Stoke Therapeutics in Q3 2020 and held it in 1 quarter.
  • Paces Ferry Wealth Advisors's Stoke Therapeutics position peaked at $3K in Q3 2020.
  • 93 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q4 2020.

Based on Paces Ferry Wealth Advisors's 13F filing for Q4 2020, filed 5 Mar 2021.